Package 0115-1725-01

{"route": ["ORAL"], "spl_id": "1987e911-c9f4-4425-9e48-3adc3a5f92f7", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "unii": ["32HRV3E3D5"], "rxcui": ["239239", "242831"], "spl_set_id": ["f21314eb-3581-4e06-9fe7-8239cc80ba11"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-01)", "package_ndc": "0115-1725-01", "marketing_start_date": "20140929"}, {"sample": false, "description": "1000 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-03)", "package_ndc": "0115-1725-03", "marketing_start_date": "20140929"}], "brand_name": "Ultramicrosize Griseofulvin", "product_id": "0115-1725_1987e911-c9f4-4425-9e48-3adc3a5f92f7", "dosage_form": "TABLET, COATED", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "0115-1725", "generic_name": "Ultramicrosize Griseofulvin Tablets", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ultramicrosize Griseofulvin", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "250 mg/1"}], "application_number": "ANDA204371", "marketing_category": "ANDA", "marketing_start_date": "20140929", "listing_expiration_date": "20261231"}